Prospective assessment of suicidal ideation and behavior: An internet survey of pharmaceutical sponsor practices

Innovations in Clinical Neuroscience

Volumn 11, Issue 9-10, 2014, Pages 14-22

  Chappell, Phillip B ^a   Mahableshwarkar, Atul R ^b   Alphs, Larry D ^c   Bangs, Mark E ^d   Butler, Adam ^e   Dubrava, Sarah J ^a   Greist, John H ^f   Lenderking, William R ^g   Mundt, James C ^h   Stewart, Michelle ^a  

^a PFIZER INC   (United States)

^b Takeda Pharmaceuticals   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e Bracket   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g EVIDERA   (United States)

^h Center for Telepsychology   (United States)

Author keywords

C SSRS in industry studies; Prospective assessment of suicidal ideation and behavior in industry studies

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); COLUMBIA SUICIDE SEVERITY RATING SCALE; HUMAN; INTERNET; MENTAL DISEASE ASSESSMENT; PROSPECTIVE STUDY; QUESTIONNAIRE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION;

EID: 84938085209     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. United States Food and Drug Administration, United States Department of Health and Human Services. Guidance for Industry: Suicidality: Prospective Assessment of Occurrence in Clinical Trials, Draft Guidance September 2010 https://www.federalregister.gov/artic les/2010/09/09/2010-22404/draftguidance- for-industry-onsuicidality- prospective-assessmentof- occurrence-in-clinical-trials Accessed October 1, 2014
2. United States Food and Drug Administration, United States Department of Health and Human Services. Guidance for Industry: Suicidality: Prospective Assessment of Occurrence in Clinical Trials, Draft Guidance August 2012. Revision 1 http://www.fda.gov/downloads/Drug s/Guidances/UCM225130.pdfAccessed October 1, 2014
3. Stewart M, Butler A, Alphs L, et al Study site experiences and attitudes towards prospective assessments of suicidal ideation and behavior in clinical trials: Results of an internet-based survey. Innov Clin Neurosci 2013;10(5–6):20S–28S
4. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C–CASA): classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007;164:1035–1043
5. Posner KP, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011; 168:1266–1277
6. Mundt JC, Greist JH, Gelenberg AJ, et al. Feasibility and validation of a computer-automated Columbia- Suicide Severity Rating Scale using interactive voice response technology. J Psych Res. 2010; 44(16): 1224–1228
7. Mundt JC, Greist JH, Jefferson JW, et al. Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale. J Clin Psychiatry. 2013;74(9):887–93
8. Coric V, Stock EG, Pultz J, et al Sheehan Suicidality Tracking Scale (S–STS): Preliminary results from a multicenter clinical trial in generalized anxiety disorder Psychiatry(Edgmont) 2009;6(1):26–31
9. Lindenmayer JP, Czobor P, Alphs L, et al, InterSePT Study Group The InterSePT Scale for Suicidal Thinking reliability and validity Schizophr Res. 2003; 63:161–70
10. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 20:22–33
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 ;23:56–62
12. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9
13. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606–13
14. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18(1):65–87
15. Poznanski EO, Grossman JA, Buchsbaum Y, et al. Preliminary studies of the reliability and validity of the Children’s Depression Rating Scale. J Am Acad Child Psychiatry 1984;23(2):191–7
16. Columbia University Medical Center. Center for Suicide Assessment. Columbia-Suicide Severity Rating Scale (C-SSRS)http://www.cssrs.columbia.edu/scal es_cssrs.html. Accessed October 8, 2014
17. Reynolds WM. Psychometric characteristics of the Adult Suicidal Ideation Questionnaire in college students. J Pers Assess 1991;56(2):289–307
18. Gassman-Mayer C, Jiang K, McSorley P, et al. Clinical and statistical assessment of suicidal ideation and behavior in pharmaceutical trials. Clin Pharmacol Ther 2011;90(4):554–560